Immucell (ICCC) Goodwill & Intangibles (2016 - 2026)
Immucell's (ICCC) quarterly Goodwill & Intangibles came in at $95557.0 in Q4 2025, down 66.66% YoY from $286597.0 in Q4 2024, and down 4.76% on a QoQ basis from $100333.0 in Q3 2025.
Immucell (ICCC) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Immucell (ICCC) has 10 years of Goodwill & Intangibles data on file, last reported at $95557.0 in Q4 2025.
- Quarterly Goodwill & Intangibles fell 66.66% year-over-year to $95557.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $95557.0 (down 66.66% YoY) and the FY2025 annual result came in at $95557.0, down 66.66% from the prior year.
- Goodwill & Intangibles fell to $95557.0 in Q4 2025, from $100333.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $286597.0 in Q3 2021 to a low of $95557.0 in Q4 2025.
- A 5-year average of $218777.8 and a median of $286597.0 in 2021 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles jumped 114.25% — and 2025, when it tumbled 66.66%.
- Tracing ICCC's Goodwill & Intangibles over 5 years: stood at $286597.0 in 2021, then changed by 0.0% to $286597.0 in 2022, then plunged by 53.33% to $133765.0 in 2023, then surged by 114.25% to $286597.0 in 2024, then plunged by 66.66% to $95557.0 in 2025.
- The last three Goodwill & Intangibles figures came in at $95557.0 (Q4 2025), $100333.0 (Q3 2025), and $105109.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95,557.00 |
| Dec 31, 2025 | 95,557.00 |
| Sep 30, 2025 | 100,333.00 |
| Jun 30, 2025 | 105,109.00 |
| Mar 31, 2025 | 286,597.00 |
| Dec 31, 2024 | 286,597.00 |
| Sep 30, 2024 | 119,437.00 |
| Jun 30, 2024 | 286,597.00 |
| Mar 31, 2024 | 286,597.00 |
| Dec 31, 2023 | 133,765.00 |
| Sep 30, 2023 | 138,541.00 |
| Jun 30, 2023 | 286,597.00 |
| Mar 31, 2023 | 286,597.00 |
| Dec 31, 2022 | 286,597.00 |
| Sep 30, 2022 | 286,597.00 |
| Jun 30, 2022 | 162,421.00 |
| Mar 31, 2022 | 286,597.00 |
| Dec 31, 2021 | 286,597.00 |
| Sep 30, 2021 | 286,597.00 |
| Jun 30, 2021 | 181,525.00 |